{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-065657","form_type":"8-K","ticker":"MYO","cik":"0001369290","company_name":"MYOMO, INC.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.081744+00:00","generated_at":"2026-05-22T07:23:02.865626+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Myomo Q1 revenue $9.8M (+162%); record 700 pipeline adds; guides Q2 $9.0-9.5M","bullets":["Revenue $9.8M (+162% YoY) on 182 units (+100%); gross margin 67.2% (up 600 bps).","Net loss $3.5M ($0.08/share) vs $3.8M loss last year; adj. EBITDA $(2.8)M.","Record 700 patients added to pipeline (+42% YoY); backlog 249 units (-9%).","Q2 2025 revenue guidance $9.0-9.5M; FY2025 reaffirmed at $50-53M.","Medicare Part B patients 59% of Q1 revenue; 45% of revenue from in-quarter authorizations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-065657","json":"https://secwatch.observer/filing/0000950170-25-065657.json","markdown":"https://secwatch.observer/filing/0000950170-25-065657.md","text":"https://secwatch.observer/filing/0000950170-25-065657.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369290/000095017025065657/0000950170-25-065657-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369290/000095017025065657/myo-20250507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:23:02.865626+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}